Oxford Biotherapeutics is a clinical-stage biotechnology company focusing on the development of antibody therapeutics for the treatment of cancer. OBT’s OGAP-verify® platform is the world's largest, cancer specific, membrane protein library, directly measuring plasma membrane protein expression in patient tumors. OGAP is used to identify novel, highly tumor specific antigens for novel first-in-class ADC, T-cell Engager (TCE) and Chimeric Antigen Receptor (CAR-T) targets. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. Our clinical and pre-clinical pipeline of novel biologics is balanced between internal programs, focused on ADCs and checkpoint regulators, and externally partnered programs with key innovators in oncology such as Roche, GSK and Zymeworks. We are seeking 4 motivated interns to support our Research & Development teams across multiple scientific functions. This is a paid, non-exempt position based in San Jose, California. Interns will gain hands-on exposure to a lab environment, contribute to day-to-day research activities, and learn foundational laboratory and operational skills while working alongside experienced scientists. The anticipated internship timeframe is June 1, 2026 through August 31, 2026, with flexibility depending on candidate availability and business needs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern